Mathieu Le Gars
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 29
-
- Immune responses and vaccinations 1
- T-cell and B-cell Immunology 1
- Co-authors
- JERALD C. SADOFF (10 shared papers)Hanneke Schuitemaker (8 shared papers)Frank Struyf (9 shared papers)Macaya Douoguih (9 shared papers)Jean‐Michel Sallenave (3 shared papers)Delphyne Descamps (3 shared papers)Michel Chignard (3 shared papers)Dirk Heerwegh (4 shared papers)
- Journals
- Vaccine (4 papers)New England Journal of Medicine (4 papers)Human Vaccines & Immunotherapeutics (3 papers)iScience (3 papers)Nature Communications (2 papers)
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Mathieu Le Gars
36 papers receiving 4.1k citations
Mathieu Le Gars's Hit Papers
Peers
Comparison fields: 5 of 101
- Infectious Diseases 3.2k
- Modeling and Simulation 102
- Health 164
- Immunology 223
- Toxicology 59
Countries citing papers authored by Mathieu Le Gars
This map shows the geographic impact of Mathieu Le Gars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Le Gars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Le Gars more than expected).
Fields of papers citing papers by Mathieu Le Gars
This network shows the impact of papers produced by Mathieu Le Gars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Le Gars. The network helps show where Mathieu Le Gars may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathieu Le Gars, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 Hit paper breakdown → | 2021 | 1891 |
| 2 | Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine Hit paper breakdown → | 2021 | 929 |
| 3 | 2021 | 254 | |
| 4 | 2021 | 244 | |
| 5 | 2021 | 182 | |
| 6 | Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S Hit paper breakdown → | 2022 | 179 |
| 7 | 2012 | 94 | |
| 8 | 2012 | 87 | |
| 9 | 2022 | 65 | |
| 10 | 2022 | 64 | |
| 11 | 2022 | 47 | |
| 12 | 2016 | 39 | |
| 13 | 2021 | 39 | |
| 14 | 2019 | 37 | |
| 15 | 2021 | 24 | |
| 16 | 2021 | 20 | |
| 17 | 2022 | 18 | |
| 18 | 2022 | 16 | |
| 19 | 2023 | 15 | |
| 20 | 2024 | 10 |
About Mathieu Le Gars
Mathieu Le Gars is a scholar working on Infectious Diseases, Immunology, Obstetrics and Gynecology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 39 papers that have together received 4.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (29 papers), Influenza Virus Research Studies (2 papers), Cystic Fibrosis Research Advances (2 papers), Immune responses and vaccinations (1 paper), Bacillus and Francisella bacterial research (1 paper), T-cell and B-cell Immunology (1 paper), Single-cell and spatial transcriptomics (1 paper) and Viral Infections and Immunology Research (1 paper). The work is most often cited by research in Infectious Diseases (3.2k citations), Modeling and Simulation (102 citations), Health (164 citations), Immunology (223 citations) and Toxicology (59 citations). Mathieu Le Gars has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include JERALD C. SADOFF, Hanneke Schuitemaker, Frank Struyf, Macaya Douoguih, Jean‐Michel Sallenave, Delphyne Descamps, Michel Chignard, Dirk Heerwegh, Anne Marit de Groot and Johan Van Hoof. Their work appears in journals such as Vaccine, New England Journal of Medicine, Human Vaccines & Immunotherapeutics, iScience and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.